(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of UCK2 mRNA] CTD PMID:31150632 1,1-dichloroethene decreases expression ISO RGD:1312516 6480464 vinylidene chloride results in decreased expression of UCK2 mRNA CTD PMID:26682919 1,2-dimethylhydrazine multiple interactions ISO RGD:1312516 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of UCK2 mRNA] CTD PMID:22206623 1,2-dimethylhydrazine increases expression ISO RGD:1312516 6480464 1, 2-Dimethylhydrazine results in increased expression of UCK2 mRNA CTD PMID:22206623 1-chloro-2,4-dinitrobenzene increases expression ISO RGD:1312516 6480464 Dinitrochlorobenzene results in increased expression of UCK2 mRNA CTD PMID:21404309 17alpha-ethynylestradiol affects expression ISO RGD:1312516 6480464 Ethinyl Estradiol affects the expression of UCK2 mRNA CTD PMID:17555576 17alpha-ethynylestradiol increases expression ISO RGD:1312516 6480464 Ethinyl Estradiol results in increased expression of UCK2 mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO RGD:1312516 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UCK2 mRNA CTD PMID:17942748 17beta-estradiol increases expression ISO RGD:1602230 6480464 Estradiol results in increased expression of UCK2 mRNA CTD PMID:19167446 more ... 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1602230 6480464 Dihydrotestosterone results in increased expression of UCK2 mRNA CTD PMID:29581250 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1312516 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UCK2 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of UCK2 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1602230 6480464 Tetrachlorodibenzodioxin results in decreased expression of UCK2 mRNA CTD PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1312516 6480464 Tetrachlorodibenzodioxin affects the expression of UCK2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1312516 6480464 Tetrachlorodibenzodioxin results in increased expression of UCK2 mRNA CTD PMID:17942748 , PMID:19770486 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1602230 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of UCK2 mRNA CTD PMID:28628672 3-methylcholanthrene decreases expression ISO RGD:1312516 6480464 Methylcholanthrene results in decreased expression of UCK2 mRNA CTD PMID:25926378 4,4'-sulfonyldiphenol decreases expression ISO RGD:1312516 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of UCK2 mRNA CTD PMID:33297965 4-(ethoxymethylene)-2-phenyloxazol-5-one increases expression ISO RGD:1312516 6480464 Oxazolone results in increased expression of UCK2 mRNA CTD PMID:21404309 5-fluorouracil affects response to substance ISO RGD:1602230 6480464 UCK2 protein affects the susceptibility to Fluorouracil CTD PMID:15548681 5-fluorouracil decreases expression ISO RGD:1602230 6480464 Fluorouracil results in decreased expression of UCK2 mRNA CTD PMID:19219653 acrylamide decreases expression ISO RGD:1602230 6480464 Acrylamide results in decreased expression of UCK2 mRNA CTD PMID:32763439 aflatoxin B1 decreases expression ISO RGD:1312516 6480464 Aflatoxin B1 results in decreased expression of UCK2 mRNA CTD PMID:19770486 aflatoxin B1 increases expression ISO RGD:1602230 6480464 Aflatoxin B1 results in increased expression of UCK2 mRNA CTD PMID:22100608 , PMID:27153756 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of UCK2 mRNA CTD PMID:16483693 atrazine increases expression ISO RGD:1602230 6480464 Atrazine results in increased expression of UCK2 mRNA CTD PMID:22378314 benzo[a]pyrene decreases expression ISO RGD:1312516 6480464 Benzo(a)pyrene results in decreased expression of UCK2 mRNA CTD PMID:19770486 benzo[a]pyrene increases methylation ISO RGD:1602230 6480464 Benzo(a)pyrene results in increased methylation of UCK2 3' UTR CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1312516 6480464 Benzo(a)pyrene results in increased expression of UCK2 mRNA CTD PMID:22228805 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1602230 6480464 7 more ... CTD PMID:19150397 , PMID:20382639 benzo[e]pyrene increases methylation ISO RGD:1602230 6480464 benzo(e)pyrene results in increased methylation of UCK2 intron CTD PMID:30157460 benzoates decreases expression ISO RGD:1602230 6480464 Benzoates analog results in decreased expression of UCK2 mRNA CTD PMID:29472718 beta-naphthoflavone decreases expression ISO RGD:1602230 6480464 beta-Naphthoflavone results in decreased expression of UCK2 mRNA CTD PMID:32858204 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of UCK2 mRNA CTD PMID:25181051 , PMID:34947998 bisphenol A increases expression ISO RGD:1602230 6480464 bisphenol A results in increased expression of UCK2 protein CTD PMID:33376534 bisphenol A decreases expression ISO RGD:1602230 6480464 bisphenol A results in decreased expression of UCK2 mRNA CTD PMID:29275510 bisphenol A decreases methylation ISO RGD:1312516 6480464 bisphenol A results in decreased methylation of UCK2 promoter CTD PMID:27312807 bisphenol A multiple interactions ISO RGD:1602230 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of UCK2 mRNA CTD PMID:28628672 cadmium dichloride increases expression ISO RGD:1602230 6480464 Cadmium Chloride results in increased expression of UCK2 mRNA CTD PMID:12160620 calcitriol multiple interactions ISO RGD:1602230 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of UCK2 mRNA CTD PMID:21592394 calcitriol decreases expression ISO RGD:1602230 6480464 Calcitriol results in decreased expression of UCK2 mRNA CTD PMID:21592394 carbamazepine affects expression ISO RGD:1602230 6480464 Carbamazepine affects the expression of UCK2 mRNA CTD PMID:24752500 carbofuran increases expression EXP 6480464 Carbofuran results in increased expression of UCK2 mRNA CTD PMID:20211217 carbon nanotube increases expression ISO RGD:1312516 6480464 Nanotubes more ... CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:1602230 6480464 CGP 52608 promotes the reaction [RORA protein binds to UCK2 gene] CTD PMID:28238834 chlordecone increases expression ISO RGD:1312516 6480464 Chlordecone results in increased expression of UCK2 mRNA CTD PMID:33711761 chromium(6+) affects expression ISO RGD:1312516 6480464 chromium hexavalent ion affects the expression of UCK2 mRNA CTD PMID:28472532 clofibrate increases expression ISO RGD:1312516 6480464 Clofibrate results in increased expression of UCK2 mRNA CTD PMID:17585979 cobalt dichloride decreases expression ISO RGD:1602230 6480464 cobaltous chloride results in decreased expression of UCK2 mRNA CTD PMID:19320972 coumestrol multiple interactions ISO RGD:1602230 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 coumestrol increases expression ISO RGD:1602230 6480464 Coumestrol results in increased expression of UCK2 mRNA CTD PMID:19167446 cyclosporin A increases expression ISO RGD:1312516 6480464 Cyclosporine results in increased expression of UCK2 mRNA CTD PMID:19770486 cyclosporin A increases expression ISO RGD:1602230 6480464 Cyclosporine results in increased expression of UCK2 mRNA CTD PMID:20106945 , PMID:25562108 dexamethasone multiple interactions ISO RGD:1602230 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of UCK2 mRNA CTD PMID:28628672 dextran sulfate multiple interactions ISO RGD:1312516 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of UCK2 mRNA CTD PMID:29950665 dibutyl phthalate decreases expression ISO RGD:1312516 6480464 Dibutyl Phthalate results in decreased expression of UCK2 mRNA CTD PMID:21266533 diclofenac affects expression ISO RGD:1602230 6480464 Diclofenac affects the expression of UCK2 mRNA CTD PMID:24752500 dioxygen multiple interactions ISO RGD:1312516 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of UCK2 mRNA CTD PMID:30529165 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of UCK2 mRNA CTD PMID:33729688 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of UCK2 mRNA CTD PMID:20211217 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of UCK2 mRNA CTD PMID:29391264 Enterolactone multiple interactions ISO RGD:1602230 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of UCK2 mRNA CTD PMID:19167446 folic acid multiple interactions ISO RGD:1312516 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of UCK2 mRNA] CTD PMID:22206623 indometacin multiple interactions ISO RGD:1602230 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of UCK2 mRNA CTD PMID:28628672 isoprenaline increases expression EXP 6480464 Isoproterenol results in increased expression of UCK2 mRNA CTD PMID:20211217 ivermectin decreases expression ISO RGD:1602230 6480464 Ivermectin results in decreased expression of UCK2 protein CTD PMID:32959892 methapyrilene increases methylation ISO RGD:1602230 6480464 Methapyrilene results in increased methylation of UCK2 intron CTD PMID:30157460 methotrexate decreases expression ISO RGD:1602230 6480464 Methotrexate results in decreased expression of UCK2 mRNA CTD PMID:24449571 methylmercury chloride increases expression ISO RGD:1602230 6480464 methylmercuric chloride results in increased expression of UCK2 mRNA CTD PMID:28001369 methylphenidate decreases expression ISO RGD:1312516 6480464 Methylphenidate results in decreased expression of UCK2 mRNA CTD PMID:22470460 methylseleninic acid decreases expression ISO RGD:1602230 6480464 methylselenic acid results in decreased expression of UCK2 mRNA CTD PMID:18548127 miconazole increases expression ISO RGD:1312516 6480464 Miconazole results in increased expression of UCK2 mRNA CTD PMID:27462272 monosodium L-glutamate multiple interactions ISO RGD:1312516 6480464 [Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of UCK2 mRNA CTD PMID:22078008 N-nitrosodiethylamine multiple interactions ISO RGD:1312516 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of UCK2 mRNA CTD PMID:24535843 nickel atom increases expression ISO RGD:1602230 6480464 Nickel results in increased expression of UCK2 mRNA CTD PMID:25583101 paracetamol affects expression ISO RGD:1312516 6480464 Acetaminophen affects the expression of UCK2 mRNA CTD PMID:17562736 paraquat increases expression EXP 6480464 Paraquat results in increased expression of UCK2 mRNA CTD PMID:32680482 phenobarbital multiple interactions ISO RGD:1312516 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of UCK2 mRNA CTD PMID:24535843 phenobarbital affects expression ISO RGD:1602230 6480464 Phenobarbital affects the expression of UCK2 mRNA CTD PMID:19159669 pirinixic acid increases expression ISO RGD:1312516 6480464 pirinixic acid results in increased expression of UCK2 mRNA CTD PMID:18301758 potassium dichromate decreases expression ISO RGD:1602230 6480464 Potassium Dichromate results in decreased expression of UCK2 protein CTD PMID:23718831 resveratrol multiple interactions ISO RGD:1602230 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of UCK2 mRNA CTD PMID:19167446 silicon dioxide increases expression ISO RGD:1602230 6480464 Silicon Dioxide analog results in increased expression of UCK2 mRNA CTD PMID:25895662 sodium arsenate increases expression ISO RGD:1312516 6480464 sodium arsenate results in increased expression of UCK2 mRNA CTD PMID:30953684 sodium arsenite increases expression ISO RGD:1602230 6480464 sodium arsenite results in increased expression of UCK2 mRNA CTD PMID:34032870 tamoxifen affects expression ISO RGD:1312516 6480464 Tamoxifen affects the expression of UCK2 mRNA CTD PMID:17555576 tert-butyl hydroperoxide increases expression ISO RGD:1602230 6480464 tert-Butylhydroperoxide results in increased expression of UCK2 mRNA CTD PMID:15336504 testosterone multiple interactions ISO RGD:1602230 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of UCK2 mRNA CTD PMID:21592394 testosterone decreases expression ISO RGD:1602230 6480464 Testosterone results in decreased expression of UCK2 mRNA CTD PMID:21592394 tetrachloromethane affects expression ISO RGD:1312516 6480464 Carbon Tetrachloride affects the expression of UCK2 mRNA CTD PMID:17484886 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of UCK2 mRNA] CTD PMID:31150632 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of UCK2 mRNA CTD PMID:31150632 tetrachloromethane increases expression ISO RGD:1312516 6480464 Carbon Tetrachloride results in increased expression of UCK2 mRNA CTD PMID:17484886 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of UCK2 mRNA CTD PMID:23411599 titanium dioxide increases expression ISO RGD:1312516 6480464 titanium dioxide results in increased expression of UCK2 mRNA CTD PMID:23557971 , PMID:27760801 titanium dioxide multiple interactions ISO RGD:1312516 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of UCK2 mRNA CTD PMID:29950665 toluene 2,4-diisocyanate increases expression ISO RGD:1312516 6480464 Toluene 2, 4-Diisocyanate results in increased expression of UCK2 mRNA CTD PMID:21404309 trichostatin A affects expression ISO RGD:1602230 6480464 trichostatin A affects the expression of UCK2 mRNA CTD PMID:28542535 trimellitic anhydride increases expression ISO RGD:1312516 6480464 trimellitic anhydride results in increased expression of UCK2 mRNA CTD PMID:19042947 urethane decreases expression ISO RGD:1602230 6480464 Urethane results in decreased expression of UCK2 mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:1312516 6480464 Valproic Acid affects the expression of UCK2 mRNA CTD PMID:17963808 valproic acid decreases expression ISO RGD:1312516 6480464 Valproic Acid results in decreased expression of UCK2 mRNA CTD PMID:21427059 valproic acid affects expression ISO RGD:1602230 6480464 Valproic Acid affects the expression of UCK2 mRNA CTD PMID:25979313 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of UCK2 mRNA CTD PMID:23034163
